As rates of obesity, as defined by body mass index (BMI), continue to climb in the United States, so have efforts to lose weight, including a new era of weight-loss drugs.

At AHA, Phase 2 results from Eli Lilly and Silence Therapeutics are seen as signs of a "major new path" of cardiovascular ...

Many people know about the importance of being less sedentary, but a new study shows just how much you need to move for a ...

New research indicates that people with cardiovascular-kidney-metabolic syndrome may have a higher risk of developing ...

New research from Salk Institute scientists describes how another class of lipids, called sphingolipids, contributes to ...

Deaths from cardiovascular disease have surged among adults ages 25 to 64 living in rural areas, a new study shows.

Shared genetic factors may drive both osteoarthritis and cardiovascular disease, suggesting a common genetic basis that ...

A recent study published in the Journal of Translational Internal Medicine reveals insights into the broader impact of ...

Like a fire alarm sending signals to evacuate a smoky building, the immune system has internal guards to help the body sense ...

Experts have started thinking more broadly about what puts a person at risk for heart disease, still the leading killer in the U.S.

For Esperion Therapeutics, 2024 has marked a pivotal transformation in its mission to combat cardiovascular disease. | ...